Search results
AstraZeneca finalizes Fusion Pharmaceuticals buyout By Investing.com
Investing.com· 1 day agoThis move is aligned with AstraZeneca (NASDAQ:AZN)'s strategy to advance cancer therapy by focusing...
AstraZeneca Buy rating, stock target reiterated on consistent presence By Investing.com
Investing.com· 8 hours agoOn Wednesday, Citi reaffirmed its Buy rating on AstraZeneca (NASDAQ:AZN) shares with a steady price...
Deutsche Bank maintains 'Hold' on AstraZeneca post ASCO conference By Investing.com
Investing.com· 11 hours agoOn Monday, Deutsche Bank (ETR:DBKGn) reiterated a Hold rating and a price target of GBP110.00 on...
AstraZeneca completes acquisition of biopharma company Fusion Pharma
dpa international via Yahoo Finance· 15 hours agoBritish pharmaceutical company AstraZeneca on Wednesday announced the completion of the acquisition...
Data Science Hiring Process at AstraZeneca
Analytics India Magazine· 10 hours agoWith over 45 years of presence in India, British-Swedish pharmaceutical and biotechnology giant AstraZeneca has data science and AI capabilities deeply ingrained across its ...
AstraZeneca completes Fusion Pharmaceuticals acquisition
Pharmaceutical Technology via Yahoo Finance· 14 hours agoAstraZeneca has announced the conclusion of its acquisition of clinical-stage biopharmaceutical...
Why CEO AstraZeneca believes the drugmaker can almost double revenue by 2030
CNBC· 24 hours agoAstraZeneca CEO Pascal Soriot explained in a Tuesday interview with CNBC's Jim Cramer why the...
This Pharma Stock Is Poised to Keep Outperforming the S&P 500
Motley Fool via Yahoo Finance· 6 days agoAstraZeneca has quietly delivered market-beating results since 2014. Despite skepticism, the company...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 4 hours agoThe Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding (MoU) with AstraZeneca during BIO International ...
Astrazeneca (AZN) Beats Stock Market Upswing: What Investors Need to Know
Zacks via Yahoo Finance· 2 days agoAstrazeneca (AZN) closed the most recent trading day at $78.99, moving +1.24% from the previous...
